Skyrizi 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FYBN7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $91,069
Award facts
- Contract value 100% obligated
- $91,069.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order contract from the Defense Logistics Agency (DLA) on May 30, 2025, valued at $91,069.46 for the supply of Skyrizi 150 mg/ml syringes. The contract is a firm fixed-price delivery order with a completion date of June 2, 2025, and was awarded without set-aside restrictions through competitive procurement. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a potential value of $999,999,999 and extends through December 2026. This comprehensive prime vendor agreement enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally.
The delivery order represents a continuation of AmerisourceBergen's critical role as a federal pharmaceutical supplier to the Defense Health Agency and other military healthcare entities. The DLA, which operates as the primary supply chain organization for the Department of Defense, utilizes indefinite delivery contracts with pharmaceutical prime vendors to ensure consistent access to medications and medical supplies across the military healthcare system. AmerisourceBergen's competitive award under this IDC reflects its established capability to meet federal procurement requirements for specialized pharmaceutical products, with the company demonstrating versatility in fulfilling both large-value orders and smaller specialized transactions across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FYBN7?
SPE2DB25FYBN7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FYBN7 worth?
The government has obligated $91,069 on SPE2DB25FYBN7.
Is contract SPE2DB25FYBN7 an order under another contract?
Yes. SPE2DB25FYBN7 is a delivery order under SPE2DB24D1104, an indefinite delivery contract.
Was contract SPE2DB25FYBN7 competed?
The extent of competition for SPE2DB25FYBN7 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award